Table 3 most added and most reduced PIM prescriptions in the pre-, peri- and post-hospitalization period
From Pre-hospitalization (Q2) to Hospitalization (H) | |||||||
Most added | Total prescriptions | Changes (n) | Most reduced | Total prescriptions | Changes (n) | ||
ATC | Q2 | H | ∆Q2/H | ATC | Q2 | H | ∆Q2/H |
Paraffin | 75 | 746 | + 671 | Ketoprofen | 125 | 1 | -124 |
Lorazepam | 434 | 871 | + 437 | Acemetacin | 182 | 78 | − 104 |
Clonidine | 12 | 448 | + 436 | Etoricoxib | 98 | 8 | −90 |
From Hospitalization (H) to Post-hospitalization (Q3) | |||||||
Most added | Total prescriptions | Changes (n) | Most reduced | Total prescriptions | Changes (n) | ||
ATC | H | Q3 | ∆H/Q3 | ATC | Q2 | H | ∆H/Q3 |
Ketoprofen | 1 | 97 | + 96 | Paraffin | 746 | 150 | − 596 |
Sodium picosulfate | 73 | 138 | + 65 | Clonidine | 448 | 12 | −436 |
Acemetacin | 78 | 138 | + 60 | Lorazepam | 871 | 444 | − 427 |
From Pre-hospitalization (Q2) to Post-hospitalization (Q3) | |||||||
Most added | Total prescriptions | Changes (n) | Most reduced | Total prescriptions | Changes (n) | ||
ATC | Q2 | Q3 | ∆Q3/Q2 | ATC | Q2 | Q3 | ∆Q3/Q2 |
Paraffin | 75 | 150 | + 75 | Diclofenac | 1136 | 978 | − 158 |
Zolpidem | 421 | 490 | + 69 | Etoricoxib | 98 | 50 | −48 |
Sodium picosulfate | 87 | 138 | + 51 | Acemetacin | 182 | 138 | −44 |